Search

everythinglearnresearchcommunity

for

Search:↓

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

Stem cell therapy shows promise for better burn healing but needs more research and standardization.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

COVID-19 vaccines are generally safe for people with lupus, though some may experience mild flare symptoms.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Early diagnosis and treatment of systemic-onset juvenile idiopathic arthritis are crucial for improvement.

Stem cells, especially from fat tissue and Wharton's jelly, can potentially regenerate hair follicles and treat hair loss, but more research is needed to perfect the treatment.

Stem cell therapy shows promise in improving burn wound healing.

Dexamethasone mini-pulse therapy is effective for alopecia areata but less effective for those with early onset or hypothyroidism.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Digital gangrene can be an initial symptom of late-onset systemic lupus erythematosus.

New treatments for alopecia show promise in restoring hair growth by targeting immune and hormonal factors.

Combining stress management and Minoxidil helps treat stress-related hair loss and improve well-being.

Digital gangrene can be an unusual first sign of late-onset lupus.

Digital gangrene can be a rare first sign of late-onset systemic lupus erythematosus.

Digital gangrene can be an early sign of late-onset systemic lupus erythematosus.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

FCER1A and RGS1 may help diagnose and treat systemic lupus erythematosus.

Stem cell therapy is promising for treating various health conditions, but more research is needed to understand its full potential and address challenges.

Certain genetic markers can indicate higher or lower risk for systemic lupus erythematosus.

Systemic lupus erythematosus treatment can restore vision in patients with retinal artery occlusion.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Tiny vesicles from stem cells could be a new treatment for healing wounds.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

Mesenchymal stem cells may effectively treat and prevent allergic skin conditions.

A Japanese man with rare skin conditions improved with hydroxychloroquine treatment.

Mycophenolate mofetil is effective for treating severe lupus nephritis in children.